An analytical study about the operational effectiveness of the Covid Control Room in a Medical College of Northern India
DOI:
https://doi.org/10.47203/IJCH.2021.v33i04.005Keywords:
COVID – 19, Pandemic, Health Seeking Behavior, Information SystemAbstract
Muzzafarnagar Medical College (MMC), Muzzafarnagar was declared a designated covid hospital by the Uttar Pradesh State Government. A Covid Control Room (CCR) was hence established to manage the disaster. Aims & Objectives: The CCR worked as the operational brain of MMC. Study Setting: Muzzafarnagar Medical College, Muzzafarnagar, Uttar Pradesh, India. Study Design: A hospital record based observational study. Material Methods: A total of 1132 admitted covid positive patients in three months constituted the study population. The CCTV cameras were installed inside the isolation wards, and the ICUs with 24/7 video coverage. The DGME (Uttar Pradesh) developed the Patient Information System (PIS) wherein information was uploaded in a database and WhatsApp messages were sent to the relatives twice daily. Results: The CCR received on an average 200 calls per day. A total of 12,622 calls were received in two months. With, PIS in function the no. of calls received in CCR reduced drastically. 100% coverage of the patients’ information was achieved. Conclusion: The scope of the control room has expanded considerably to address various aspects of the covid-19 pandemic crisis. These findings will be helpful as a reference for future. It is one of the first studies and unique in nature.
Downloads
References
Critical Infrastructure Operations Centre and Control Rooms; cisa.gov; April 2020 https://www.cisa.gov/sites/default/files/publications/20_0423_COVID-19_CI_Ops_Center_Control_Room_Guide.pdf
Asirvatham ES, Sarman CJ, Saravanamurthy SP, Mahalingam P, Maduraipandian S, Lakshmanan J. Who is dying from COVID-19 and when? An Analysis of fatalities in TamilNadu, India. Clinical Epidemiology and Global Health. 9 (2021) 275–279 [https://doi.org/10.1016/j.cegh.2020.09.010]
Goh KJ, Choong MC, Cheong EH, et al. Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection. Ann Acad Med Singapore. 2020;49(3):108–118.
“With very high COVID-19 testing, India's positivity rate fallen below 8%: MoHFW". The Economic Times. 18 October 2020. Retrieved 19 October 2020.
Jump up to:a b Michael Safi (21 April 2021). "India's shocking surge in Covid cases follows baffling decline". The Guardian. Retrieved 29 April 2021.
"Coronavirus | India becomes 1st country in the world to report over 4 lakh new cases on 30 April 2021". The Hindu. Special Correspondent. 30 April 2021. ISSN 0971-751X. Retrieved 2 May 2021.
Jump up to:a b "India coronavirus: New record deaths as virus engulfs India". BBC News. 2 May 2021. Retrieved 3 May 2021.
Yeung, Jessie (28 April 2021). "As Covid sweeps India, experts say cases and deaths are going unreported". CNN.
Gettleman, Jeffrey; Yasir, Sameer; Kumar, Hari; Raj, Suhasini; Loke, Atul (24 April 2021). "As Covid-19 Devastates India, Deaths Go Undercounted". The New York Times. ISSN 0362-4331. Retrieved 3 May 2021.
Guan W-J, Liang W-H, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.
Adams SH, Park MJ, Schaub JP, Brindis CD, Irwin Jr CE. Medical vulnerability of young adults to severe COVID-19 illness—data from the national health interview survey. J Adolesc Health. 2020;67(3):362–368.
Napoli. MCMRACSCDRD. Evaluation and treatment coronavirus (COVID-19). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
Feng D, Jia N, Fang L-Q et al. Duration of symptom onset to hospital admission and admission to discharge or death in SARS in mainland China: a descriptive study. Trop Med Int Health. 2009;14(s1):28–35.
CDC. Severe. Outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, february 12-march 16, 2020. Morb Mortal Wkly Rep. 2020; 69 (12): 343–346.
Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959–9981.
Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669–677.
Li Y, Jerkic M, Slutsky AS, Zhang H. Molecular mechanisms of sex bias differences in COVID-19 mortality. Crit Care. 2020;24(1):405.
National IIPS. Family Health Survey-2017 (NFHS-4). New Delhi: Ministry of Heallth and Family Welfare,Government of India; 2017.
Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
Liu H, Chen S, Liu M, Nie H, Lu H. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and metaanalysis. Aging Dis. 2020;11(3):668–678.
Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372–1379.
Pachiega J, Afonso AJdS, Sinhorin GT, et al. Chronic Heart Diseases as the Most Prevalent Comorbidities Among Deaths by COVID-19 in Brazil. Jour of the Institute of Trop Medicine of Sao Paulo;; 2020:62.
Korean Society of Infectious D, Korea Centers for Disease C, Prevention. Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to march 10, 2020. J Kor Med Sci. 2020;35(12):e132–e.
Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, Peiris M, Poon LLM, Zhang W. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020. [Epub ahead of print]. Available from: 10.1016/S1473-3099(20)30232-2.
Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging. 2020; 12(10): 9959–9981. Available from: https://doi.org/10.18632/aging.103344
Downloads
Published
How to Cite
License
Copyright (c) 2022 Indian Journal of Community Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
